Answers are grounded in this paper and cite their sources.
Since the 2012 fungal meningitis outbreak caused by a compounded drug that had been prepared under inappropriate conditions, the FDA’s experience in monitoring pharmacy compounding has demonstrated the need for further improvement in compounding practices.
No takes yet. Share an insight, caveat, or question.
Woodcock et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: